This supports the results of previous studies which demonstrated that these two biomarkers are significantly correlated in tongue cancer [47], neuroendocrine carcinoma of the lung [48], thymic carcinoma [49] and breast cancer [50], indicating that SLC7A5 is critical for proliferation in cancer cells. Here, SLC7A5 is linked to thymic carcinoma.